Normocalcemia in a Hypoparathyroid Patient with Sarcoidosis: Evidence for Parathyroid-Hormone-Independent Synthesis of 1,25 Dihydroxyvitamin D

  1. JOSEPH ZIMMERMAN, M.D.;
  2. MICHAEL F. HOLICK, Ph.D., M.D.; and
  3. JUSTIN SILVER, M.D., Ph.D.
  1. Hadassah University Hospital;
    Jerusalem,
    Israel. Massachusetts General Hospital;
    Boston, Massachusetts

    Excerpt

    Sarcoidosis may lead to hypercalcemia due to the increased levels of serum 1,25 dihydroxyvitamin D (1,25(OH)2D) (1). This biologically active metabolite of vitamin D is produced by 1 α hydroxylation of 25 hydroxy vitamin D in the kidneys (2), a reaction normally stimulated by parathyroid hormone (PTH). A patient with postoperative hypoparathyroidism developed sarcoidosis and an elevated serum 1,25(OH)2D level, resulting in a prolonged remission of hypocalcemia.

    A 49-year old woman was hospitalized in May 1978 because of fever and precordial pain. The patient had had a subtotal thyroidectomy in 1953 for a diffuse, nontoxic goiter. She later developed tetany,

    This 100-word excerpt has been provided in the absence of an abstract.

    Article and Author Information

    • ▸Request for reprints should be addressed to Justin Silver, M.D.; Department of Nephrology, Hadassah Hospital, P.O.B. 12000; Jerusalem, Israel.

    « Previous | Next Article »Table of Contents